|
COPYRIGHT 2004 International Medical News Group
BERLIN -- A portrait is emerging of the osteoarthritis patient at risk for rapid disease progression, Tim D. Spector, M.D., said at the annual European Congress of Rheumatology.
Most people who live long enough will eventually get osteoarthritis (OA). A more interesting clinical question is who will fall into the small subgroup--about 5% of OA patients--who develop rapidly progressive disease. Those are the patients needed in trials of potential disease-modifying antirheumatic drugs (DMARDs) to avoid extraordinarily large studies. And once effective DMARDs are...
Read the full article for free courtesy of your local library.
| 
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
